# Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines

> **NCT03164590** · PHASE4 · COMPLETED · sponsor: **Assiut University** · enrollment: 60 (actual)

## Conditions studied

- Endometrial Adenocarcinoma

## Interventions

- **DRUG:** Ketamine
- **DRUG:** dexmedetomidine
- **DRUG:** bupivacaine

## Key facts

- **NCT ID:** NCT03164590
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2018-08-01
- **Final completion:** 2018-09-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03164590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03164590, "Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03164590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*